07.08.2024 13:17:41
|
Charles River Laboratories International Inc. Q2 Profit Decreases, But Beats Estimates
(RTTNews) - Charles River Laboratories International Inc. (CRL) announced earnings for second quarter that decreased from the same period last year but beat the Street estimates.
The company's earnings came in at $94.08 million, or $1.74 per share. This compares with $97.02 million, or $1.89 per share, in last year's second quarter.
Excluding items, Charles River Laboratories International Inc. reported adjusted earnings of $144.94 million or $2.80 per share for the period.
Analysts on average had expected the company to earn $2.39 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter fell 3.1% to $1.026 billion from $1.059 billion last year.
Charles River Laboratories International Inc. earnings at a glance (GAAP) :
-Earnings (Q2): $94.08 Mln. vs. $97.02 Mln. last year. -EPS (Q2): $1.74 vs. $1.89 last year. -Revenue (Q2): $1.026 Bln vs. $1.059 Bln last year.
-Guidance: Full year EPS guidance: $9.90 – $10.20

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Charles River Laboratories International Inc.mehr Nachrichten
24.02.25 |
Börse New York: S&P 500 zum Handelsende in Rot (finanzen.at) | |
24.02.25 |
Freundlicher Handel in New York: Am Montagnachmittag Gewinne im S&P 500 (finanzen.at) | |
24.02.25 |
Montagshandel in New York: Börsianer lassen S&P 500 am Mittag steigen (finanzen.at) | |
24.02.25 |
Handel in New York: S&P 500 zum Start schwächer (finanzen.at) | |
24.02.25 |
S&P 500-Wert Charles River Laboratories International-Aktie: So viel hätten Anleger mit einem Investment in Charles River Laboratories International von vor 5 Jahren verloren (finanzen.at) | |
19.02.25 |
Freundlicher Handel: S&P 500 mittags in Grün (finanzen.at) | |
18.02.25 |
Ausblick: Charles River Laboratories International stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net) | |
17.02.25 |
S&P 500-Wert Charles River Laboratories International-Aktie: So viel Verlust wäre bei einem Investment in Charles River Laboratories International von vor 3 Jahren angefallen (finanzen.at) |
Analysen zu Charles River Laboratories International Inc.mehr Analysen
Aktien in diesem Artikel
Charles River Laboratories International Inc. | 158,15 | 0,16% |
|